Jiang Zhong Pharmaceutical Co.,Ltd (SHA: 600750)

Market Cap	13.19B
Revenue (ttm)	4.20B
Net Income (ttm)	747.25M
Shares Out	622.83M
EPS (ttm)	1.18
PE Ratio	17.94
Forward PE	14.91
Dividend	1.30 (6.14%)
Ex-Dividend Date	Jun 13, 2024

Volume	2,802,055
Open	21.30
Previous Close	21.21
Day's Range	21.15 - 21.40
52-Week Range	17.80 - 28.58
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Jiang Zhong Pharmaceutical Co.,Ltd

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. The company offers OTC products for spleen and stomach, intestinal tract, anorectal, throat cough and asthma, supplements and minerals, and chronic diseases. It also offers health products for high-end nourishment, rehabilitation nutrition, gastrointestinal health, liver and gallbladder health, dietary nutrition, basic vitamins, personal care essential oils, and other businesses; and pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 4,013
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600750

Financial Performance

In 2023, 600750's revenue was 4.39 billion, an increase of 13.00% compared to the previous year's 3.89 billion. Earnings were 708.29 million, an increase of 18.40%.